Vol 5, No 2 (2025)

decorative image of the issue cover

Reimbursement Recommendations

Clascoterone (Winlevi)

CDA-AMC

Published February 25, 2025

PDF HTML

Pembrolizumab (Keytruda)

CDA-AMC

Published February 19, 2025

PDF HTML

Pembrolizumab (Keytruda)

CDA-AMC

Published February 18, 2025

PDF HTML

Zolbetuximab for Injection (Vyloy)

CDA-AMC

Published February 14, 2025

PDF HTML

Momelotinib (Ojjaara)

CDA-AMC

Published February 12, 2025

PDF HTML

Zilucoplan (Zilbrysq)

CDA-AMC

Published February 11, 2025

PDF HTML

Reimbursement Reviews

Clindamycin Plus Benzoyl Peroxide and Adapalene (Cabtreo)

CDA-AMC

Published February 21, 2025

PDF HTML

Sotatercept (Winrevair)

CDA-AMC

Published February 19, 2025

PDF HTML

Eplontersen (Wainua)

CDA-AMC

Published February 18, 2025

PDF HTML

Burosumab (Crysvita)

CDA-AMC

Published February 12, 2025

PDF HTML

Lebrikizumab (Ebglyss)

CDA-AMC

Published February 11, 2025

PDF HTML

Baricitinib (Olumiant)

CDA-AMC

Published February 7, 2025

PDF HTML

Abemaciclib (Verzenio)

CDA-AMC

Published February 7, 2025

PDF HTML

Health Technology Reviews

Crushed Buprenorphine-Naloxone Tablets

CDA-AMC

Published February 27, 2025

PDF HTML

Subtalar Joint Arthroereisis

CDA-AMC

Published February 21, 2025

PDF HTML

High-Dose Bupropion for Depression

CDA-AMC

Published February 6, 2025

PDF HTML

View All Issues